<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Anesthesia for patients with chronic obstructive pulmonary disease</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Anesthesia for patients with chronic obstructive pulmonary disease</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Anesthesia for patients with chronic obstructive pulmonary disease</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Rachel Budithi, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sylvia Y Dolinski, MD, FCCP</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Peter D Slinger, MD, FRCPC</a></dd><dt><span> </span>Deputy Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Nancy A Nussmeier, MD, FAHA</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Paul Dieffenbach, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Nov 17, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H239120578"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Chronic obstructive pulmonary disease (COPD) and its subtypes (emphysema, chronic bronchitis, and chronic obstructive asthma) are important risk factors for postoperative pulmonary complications (eg, pneumonia, reintubation after initial extubation, and prolonged intubation &gt;48 hours), resulting in increased length of hospital stay and mortality.</p><p>This topic will discuss anesthetic management of patients with COPD. Details regarding anesthetic management of patients with asthma are addressed in another topic. (See  <a class="medical medical_review" href="/d/html/94358.html" rel="external">"Anesthesia for adult patients with asthma"</a>.)</p><p>Medical evaluation of preoperative pulmonary risk and perioperative strategies to reduce pulmonary complications are discussed separately.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/6917.html" rel="external">"Evaluation of perioperative pulmonary risk"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/6970.html" rel="external">"Strategies to reduce postoperative pulmonary complications in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/4401.html" rel="external">"Overview of the management of postoperative pulmonary complications"</a>.)</p><p></p><p class="headingAnchor" id="H396784802"><span class="h1">PREANESTHESIA CONSULTATION</span><span class="headingEndMark"> — </span>The goals of the preanesthesia consultation are to assess COPD severity and comorbidities that contribute to perioperative anesthetic risk, work with the patient's pulmonary specialist/primary care provider to optimize the patient's medical condition, develop an anesthetic care plan, and educate the patient regarding anesthetic care.</p><p></p><p class="headingAnchor" id="H396784809"><span class="h2">Risk factors for pulmonary complications</span><span class="headingEndMark"> — </span>By definition, patients with COPD have airflow limitation (ie, a forced expiratory volume in one second/forced vital capacity [FEV<sub>1</sub>/FVC] ratio less than 0.7 or less than the lower limit of normal) that does not reverse completely after administration of inhaled bronchodilators. The airflow limitation is caused by a variable combination of airway inflammation, scarring, and secretions. Some patients have destruction of lung parenchyma and the pulmonary capillary bed that decreases the available surface area for gas exchange and reduces tethering of the small airways. The end result is increased airflow resistance, hyperinflation due to air trapping, and decreased gas transfer, resulting in ventilation/perfusion (V/Q) mismatch, hypoxemia, and hypercapnia. With advanced COPD ventilatory responses to both hypoxia and hypercapnia may be blunted, and hypoxic pulmonary vasoconstriction attenuated. (See  <a class="medical medical_review" href="/d/html/1455.html" rel="external">"Chronic obstructive pulmonary disease: Diagnosis and staging"</a>.)</p><p>Although COPD increases risk for pulmonary complications [<a href="#rid1">1,2</a>], there is no prohibitive level of pulmonary function that contraindicates surgery. The prospective benefit of a proposed surgical procedure is weighed against evaluated risk in an individual patient with COPD  (<a class="graphic graphic_table graphicRef76906" href="/d/graphic/76906.html" rel="external">table 1</a> and <a class="graphic graphic_table graphicRef62775" href="/d/graphic/62775.html" rel="external">table 2</a> and <a class="graphic graphic_algorithm graphicRef56866" href="/d/graphic/56866.html" rel="external">algorithm 1</a>). (See  <a class="medical medical_review" href="/d/html/6917.html" rel="external">"Evaluation of perioperative pulmonary risk", section on 'Chronic obstructive pulmonary disease (COPD)'</a> and  <a class="medical medical_review" href="/d/html/6917.html" rel="external">"Evaluation of perioperative pulmonary risk", section on 'Estimating postoperative pulmonary risk'</a>.)</p><p class="headingAnchor" id="H2392450507"><span class="h3">Patient-related factors</span><span class="headingEndMark"> — </span>Relative risk of COPD and other patient-related factors are discussed in a separate topic. (See  <a class="medical medical_review" href="/d/html/6917.html" rel="external">"Evaluation of perioperative pulmonary risk", section on 'Patient-related risk factors'</a>.)</p><p>Common risk factors and comorbidities that may impact operative risk include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Age</strong> – Most patients with COPD are older adults; advancing age has an independent effect on the risk of pulmonary complications  (<a class="graphic graphic_table graphicRef76906" href="/d/graphic/76906.html" rel="external">table 1</a>) [<a href="#rid3">3</a>]. (See  <a class="medical medical_review" href="/d/html/6917.html" rel="external">"Evaluation of perioperative pulmonary risk", section on 'Age'</a> and  <a class="medical medical_review" href="/d/html/14931.html" rel="external">"Anesthesia for the older adult", section on 'Respiratory system'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Tobacco use</strong> – Ongoing cigarette smoking is an additional risk factor for pulmonary complications. (See  <a class="medical medical_review" href="/d/html/127216.html" rel="external">"Smoking or vaping: Perioperative management", section on 'Rationale for smoking cessation'</a> and  <a class="medical medical_review" href="/d/html/6917.html" rel="external">"Evaluation of perioperative pulmonary risk", section on 'Smoking'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cardiovascular disease</strong> – Ischemic heart disease, dysrhythmias, heart failure, and/or pulmonary hypertension are common comorbidities in patients with COPD, as discussed separately [<a href="#rid4">4-6</a>]. (See  <a class="medical medical_review" href="/d/html/1437.html" rel="external">"Management of the patient with COPD and cardiovascular disease"</a> and  <a class="medical medical_review" href="/d/html/1454.html" rel="external">"Arrhythmias in COPD"</a> and  <a class="medical medical_review" href="/d/html/6616.html" rel="external">"Evaluation of cardiac risk prior to noncardiac surgery"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Obstructive sleep apnea (OSA)</strong> – OSA is associated with increased risk for pulmonary and cardiac complications, and is common in patients with COPD (ie, overlap syndrome). (See  <a class="medical medical_review" href="/d/html/7680.html" rel="external">"Sleep-related breathing disorders in COPD"</a> and  <a class="medical medical_review" href="/d/html/13516.html" rel="external">"Surgical risk and the preoperative evaluation and management of adults with obstructive sleep apnea"</a> and  <a class="medical medical_review" href="/d/html/13517.html" rel="external">"Intraoperative management of adults with obstructive sleep apnea"</a>.)</p><p></p><p class="headingAnchor" id="H3290145722"><span class="h3">Procedure-related factors</span><span class="headingEndMark"> — </span>Procedure-related factors increase risk of pulmonary complications. (See  <a class="medical medical_review" href="/d/html/6917.html" rel="external">"Evaluation of perioperative pulmonary risk", section on 'Procedure-related risk factors'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Surgical site</strong> – Functional residual capacity (FRC) is reduced during anesthesia and surgery, which can lead to early airway closure and atelectasis, worsening V/Q mismatch, hypoxemia, and respiratory failure  (<a class="graphic graphic_figure graphicRef55440" href="/d/graphic/55440.html" rel="external">figure 1</a>) [<a href="#rid7">7</a>]. Proximity of the surgical procedure to the diaphragm is the primary factor determining the degree of FRC reduction and the likelihood of postoperative respiratory failure [<a href="#rid7">7-9</a>]. Thus, complications are more likely in patients undergoing thoracic and upper abdominal surgery compared with procedures in the lower abdomen and other sites. (See  <a class="medical medical_review" href="/d/html/6917.html" rel="external">"Evaluation of perioperative pulmonary risk", section on 'Surgical site'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Surgical positioning</strong> – In general, supine, Trendelenburg, lithotomy, and lateral decubitus positioning reduces FRC and leads to atelectasis  (<a class="graphic graphic_figure graphicRef55440" href="/d/graphic/55440.html" rel="external">figure 1</a>) [<a href="#rid10">10,11</a>]. Notably, prone positioning in COPD patients does not negatively affect respiratory mechanics and may improve FRC, V/Q distribution, and oxygenation [<a href="#rid12">12-14</a>]. Also, compared with normal lungs, FRC may be less reduced in the supine position in patients with COPD because of airway closure prior to alveolar collapse [<a href="#rid15">15</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Duration of surgery</strong> – Surgical time longer than five hours has been associated with increased risk of postoperative pulmonary complications [<a href="#rid16">16</a>]. (See  <a class="medical medical_review" href="/d/html/6917.html" rel="external">"Evaluation of perioperative pulmonary risk", section on 'Duration of surgery'</a>.)</p><p></p><p class="headingAnchor" id="H224274581"><span class="h3">Anesthetic factors</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sedative effects of anesthetic agents </strong>– Since COPD patients are highly sensitive to sedative and analgesic agents, use of these agents during monitored anesthesia care (MAC) can result in severe hypoventilation, with atelectasis, hypercapnia, and hypoxemia. Also in the immediate postoperative period, residual effects of anesthetic agents in the immediate postoperative period may lead to respiratory depression with hypoventilation, poor cough, and atelectasis. Thus, vigilant monitoring is necessary throughout the perioperative period.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Airway manipulation</strong> – Laryngoscopy, intubation, and extubation can cause reflex-induced bronchoconstriction that may be severe. (See  <a class="medical medical_review" href="/d/html/94358.html" rel="external">"Anesthesia for adult patients with asthma", section on 'Choice of anesthetic technique'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>General anesthesia </strong>– Use of the anesthesia breathing circuit may result in dried airway secretions, interference with surfactant production, slow mucociliary clearance, and increased permeability of the alveolar-capillary barrier [<a href="#rid17">17</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Controlled ventilation </strong>– Controlled ventilation may exacerbate hyperinflation in COPD patients when expiratory airflow limitation causes inspiration to occur prior to full exhalation of the previous breath  (<a class="graphic graphic_figure graphicRef78052" href="/d/graphic/78052.html" rel="external">figure 2</a>). This breath stacking leads to dynamic hyperinflation, which in turn can lead to increased positive end-expiratory pressure (PEEP), known as auto-PEEP [<a href="#rid18">18</a>]. The consequences of dynamic hyperinflation include worsening V/Q mismatch, hypoxemia, hypercapnia, barotrauma, and hypotension (due to impaired venous return) [<a href="#rid19">19,20</a>].</p><p></p><p class="bulletIndent1">Measurement of auto-PEEP and management of dynamic hyperinflation are discussed elsewhere:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>(See <a class="local">'Mechanical ventilation'</a> below.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>(See  <a class="medical medical_review" href="/d/html/1459.html" rel="external">"Dynamic hyperinflation in patients with COPD"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>(See  <a class="medical medical_review" href="/d/html/1632.html" rel="external">"Invasive mechanical ventilation in acute respiratory failure complicating chronic obstructive pulmonary disease", section on 'Dynamic hyperinflation'</a>.)</p><p></p><p class="headingAnchor" id="H4196390003"><span class="h2">Preoperative assessment</span><span class="headingEndMark"> — </span>Preoperative risk assessment is based on:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>History and physical examination </strong>– (See  <a class="medical medical_review" href="/d/html/94539.html" rel="external">"Preoperative evaluation for anesthesia for noncardiac surgery", section on 'Medical history and review of systems'</a> and  <a class="medical medical_review" href="/d/html/94539.html" rel="external">"Preoperative evaluation for anesthesia for noncardiac surgery", section on 'Anesthesia directed physical examination'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Laboratory tests </strong>– In selected patients using a high dose of beta-adrenergic agonists or systemic glucocorticoids, laboratory values may be obtained to check for abnormalities in electrolyte values and serum glucose. Also, preoperative anemia is investigated to rule out reversible causes before elective surgery  (<a class="graphic graphic_algorithm graphicRef120496" href="/d/graphic/120496.html" rel="external">algorithm 2</a>). Hemoglobin ≤10 g/dL has been associated with increased risk of postoperative pulmonary complications (odds ratio [OR] 3.0, 95% CI 1.4-6.5;  (<a class="graphic graphic_table graphicRef76906" href="/d/graphic/76906.html" rel="external">table 1</a>)) [<a href="#rid3">3</a>]. (See  <a class="medical medical_review" href="/d/html/6917.html" rel="external">"Evaluation of perioperative pulmonary risk", section on 'Preoperative risk assessment'</a> and  <a class="medical medical_review" href="/d/html/94347.html" rel="external">"Perioperative blood management: Strategies to minimize transfusions", section on 'Treatment of anemia'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pulmonary function tests (PFTs)</strong> – Formal assessment of PFTs, gas exchange (eg, ambulatory oximetry, six minute walk test), and less commonly, cardiopulmonary exercise testing is obtained (or reviewed) in patients with known or suspected COPD (eg, reduced exercise tolerance, COPD exacerbation in past year, cigarette smoking &gt;20 years). A risk assessment tool can be helpful in quantifying risk  (<a class="graphic graphic_table graphicRef76906" href="/d/graphic/76906.html" rel="external">table 1</a> and <a class="graphic graphic_table graphicRef62775" href="/d/graphic/62775.html" rel="external">table 2</a>) and (<a class="calc calc_professional" href="/d/html/141147.html" rel="external">calculator 1</a>). (See  <a class="medical medical_review" href="/d/html/6917.html" rel="external">"Evaluation of perioperative pulmonary risk", section on 'Preoperative risk assessment'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Arterial blood gas (ABG) </strong>– Baseline ABG analysis may be helpful in selected patients (eg, those undergoing major surgery or procedures of long duration more than three hours, particularly if FEV<sub>1</sub> is &lt;50 percent of the predicted value and in those with prior hypercapnia) [<a href="#rid9">9,21</a>]. Preoperative ABG results may be used to identify patients who will need more intense monitoring, oxygen therapy, noninvasive ventilation (NIV), or controlled mechanical ventilation in the immediate postoperative period. ABG values are also used to guide intraoperative and postoperative ventilator adjustments to maintain pressure of arterial carbon dioxide (PaCO<sub>2</sub>) near baseline in a patient with preexisting hypercapnia. (See  <a class="medical medical_review" href="/d/html/6917.html" rel="external">"Evaluation of perioperative pulmonary risk", section on 'Assessment of oxygenation and hypercapnia'</a> and <a class="local">'Management of postanesthesia care'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Risk assessment tools</strong> – Other risk assessment tools, such as the short physical performance battery that emphasizes the sit-to-stand test, have been used to predict COPD exacerbation, increased hospital length of stay, or readmission [<a href="#rid22">22</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Chest radiograph</strong> – Preoperative chest radiography (CXR) is not routinely indicated since findings rarely impact anesthetic care, but a CXR may be obtained in a patient with new lung auscultation findings, worsening respiratory symptoms, or exercise intolerance [<a href="#rid6">6</a>].</p><p></p><p class="headingAnchor" id="H396784969"><span class="h2">Preoperative interventions to optimize pulmonary function</span><span class="headingEndMark"> — </span>Achieving optimal baseline level of pulmonary function is a major preoperative goal for patients with COPD. Interventions before the day of surgery include [<a href="#rid23">23,24</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Refer patients with poorly controlled COPD for treatment </strong>– Before elective procedures, the patient's primary care clinician or pulmonologist is consulted for further treatment if the patient reports dyspnea at rest or with minimal exertion (unless this is previously known and unchanged), wheezing, copious sputum production, or evidence of active infection (eg, fever, purulent sputum), or if tachypnea, wheezing, or crackles are noted on examination. (See  <a class="medical medical_review" href="/d/html/6917.html" rel="external">"Evaluation of perioperative pulmonary risk", section on 'Clinical evaluation'</a>.)</p><p></p><p class="bulletIndent1">Patients with a COPD exacerbation can benefit from (see  <a class="medical medical_review" href="/d/html/1461.html" rel="external">"COPD exacerbations: Management"</a>) [<a href="#rid25">25,26</a>]: </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Intensification of their inhaled bronchodilator medications (eg, beta-adrenergic agonists and muscarinic antagonists [anticholinergic agents]).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A brief course of systemic glucocorticoid therapy in some cases. However, even a brief course of systemic glucocorticoids may have some adverse effects (eg, hyperglycemia, upper gastrointestinal bleeding, psychiatric disorders). (See  <a class="medical medical_review" href="/d/html/7988.html" rel="external">"Major adverse effects of systemic glucocorticoids"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Antibiotic therapy, if indicated.</p><p></p><p class="bulletIndent1">We suggest postponing elective surgery in patients with signs and symptoms of exacerbation of chronic COPD or active upper respiratory infection [<a href="#rid23">23</a>]. Time needed to return to baseline after an exacerbation is variable, so the duration of postponement should be determined on an individual basis. (See  <a class="medical medical_review" href="/d/html/6917.html" rel="external">"Evaluation of perioperative pulmonary risk", section on 'Upper respiratory infection'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Encourage smoking cessation </strong>–<strong> </strong>Patients should be counseled about cessation of smoking and/or vaping (ie, with electronic cigarettes) during the preanesthesia consultation [<a href="#rid27">27</a>]. Optimal timing of cessation is unknown, but cessation for four to eight weeks prior to surgery likely has the benefit of decreased risk of postoperative pulmonary complications [<a href="#rid28">28,29</a>]. However, even cessation for as little as two days may have some benefit (eg, decreased carboxyhemoglobin levels, elimination of nicotine effects, and improved mucociliary clearance). (See  <a class="medical medical_review" href="/d/html/127216.html" rel="external">"Smoking or vaping: Perioperative management", section on 'Helping perioperative patients quit smoking or vaping'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Initiate preoperative incentive muscle training </strong>– Preoperative instruction regarding inspiratory muscle training (ie, deep breathing exercises or self-administered incentive spirometry) may reduce the incidence of postoperative complications and can be accomplished in the preoperative anesthesia clinic [<a href="#rid30">30</a>]. Although this strategy is time-intensive and potentially expensive, there are no risks [<a href="#rid28">28,31</a>]. (See  <a class="medical medical_review" href="/d/html/6970.html" rel="external">"Strategies to reduce postoperative pulmonary complications in adults", section on 'Pulmonary prehabilitation'</a>.)</p><p></p><p class="headingAnchor" id="H46738270"><span class="h1">PERIOPERATIVE MEDICATION MANAGEMENT</span></p><p class="headingAnchor" id="H252377468"><span class="h2">Inhaled bronchodilators and glucocorticoids</span><span class="headingEndMark"> — </span>Guideline-based treatment of COPD with long-acting beta agonists (LABA), long-acting muscarinic antagonists (LAMA), and inhaled glucocorticoids may decrease postoperative pulmonary complications [<a href="#rid16">16,32</a>]. Each patient should be assessed to ensure that baseline therapy is adjusted optimally for the individual level of symptoms, risk of exacerbations, and response to therapy. (See  <a class="medical medical_review" href="/d/html/1447.html" rel="external">"Stable COPD: Initial pharmacologic management", section on 'General principles'</a>.)</p><p>Inhaled LABA and LAMA agents, as well as inhaled glucocorticoids, are continued in the perioperative period, including the usual dose on the morning of surgery, with resumption shortly after surgery [<a href="#rid17">17,28,33</a>]. Some patients may need additional doses of short-acting bronchodilators, including those who remain symptomatic with bronchospasm even after treatment with muscarinic antagonists.</p><p>For patients who require endotracheal intubation, particularly those with a history of asthma-like symptoms (ie, bronchoconstriction), we administer an inhaled, rapid-acting beta-agonist (eg, <a class="drug drug_general" data-topicid="9396" href="/d/drug information/9396.html" rel="external">albuterol</a>, either two to four puffs from a metered dose inhaler or a nebulizer treatment) within 30 minutes of intubation, and again during emergence from general anesthesia shortly before extubation. (See  <a class="medical medical_review" href="/d/html/6970.html" rel="external">"Strategies to reduce postoperative pulmonary complications in adults", section on 'Chronic obstructive lung disease'</a> and  <a class="medical medical_review" href="/d/html/94358.html" rel="external">"Anesthesia for adult patients with asthma", section on 'Premedication'</a> and <a class="local">'Emergence'</a> below.)</p><p class="headingAnchor" id="H97818647"><span class="h2">Stress-dose glucocorticoid coverage</span><span class="headingEndMark"> — </span>Patients taking oral or high-dose inhaled  (<a class="graphic graphic_table graphicRef78011" href="/d/graphic/78011.html" rel="external">table 3</a>) glucocorticoids are at risk for hypothalamic pituitary axis (HPA) suppression and adrenal insufficiency during anesthesia and surgery. The likelihood of HPA suppression is estimated based on the dose and duration of glucocorticoid therapy and is discussed separately. (See  <a class="medical medical_review" href="/d/html/146.html" rel="external">"The management of the surgical patient taking glucocorticoids"</a> and  <a class="medical medical_review" href="/d/html/7988.html" rel="external">"Major adverse effects of systemic glucocorticoids", section on 'Metabolic and endocrine effects'</a>.)</p><p>For patients with a high likelihood of adrenal suppression, supplemental glucocorticoids are given in accordance with the magnitude of the anticipated stress of the procedure  (<a class="graphic graphic_table graphicRef69479" href="/d/graphic/69479.html" rel="external">table 4</a>). Notably, the usual morning oral dose of glucocorticoid is always administered, regardless of whether additional glucocorticoid will be given just prior to the procedure. For patients taking high doses of inhaled glucocorticoids, the risk of symptomatic adrenal suppression or acute crisis appears to be very small, particularly if the daily dose is within the recommended range. (See  <a class="medical medical_review" href="/d/html/146.html" rel="external">"The management of the surgical patient taking glucocorticoids"</a> and  <a class="medical medical_review" href="/d/html/540.html" rel="external">"Major side effects of inhaled glucocorticoids", section on 'Adrenal suppression'</a>.)</p><p class="headingAnchor" id="H3148842146"><span class="h2">Other chronically administered medications</span><span class="headingEndMark"> — </span>The following medications are also notable for patients with COPD:</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="10281" href="/d/drug information/10281.html" rel="external">Theophylline</a><strong> </strong>– Theophylline is discontinued on the evening prior to surgery [<a href="#rid34">34</a>]. (See  <a class="medical medical_review" href="/d/html/4814.html" rel="external">"Perioperative medication management", section on 'Theophylline'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nicotine replacement therapy (NRT) </strong>– NRT should be continued. Overall, the likelihood that surgical patients can abstain from smoking is increased by use of NRT initiated or continued in the perioperative period. (See  <a class="medical medical_review" href="/d/html/127216.html" rel="external">"Smoking or vaping: Perioperative management", section on 'Helping perioperative patients quit smoking or vaping'</a>.)</p><p></p><p>Preoperative management of other chronically administered medications is discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/4814.html" rel="external">"Perioperative medication management"</a>.)</p><p class="headingAnchor" id="H46738119"><span class="h2">Premedication</span><span class="headingEndMark"> — </span>Anxiety in the preoperative period can lead to increased respiratory rate, which may lead to lung hyperinflation (due to breath stacking) and worsening dyspnea in a COPD patient. Sedatives titrated in very small doses (eg, <a class="drug drug_general" data-topicid="9650" href="/d/drug information/9650.html" rel="external">midazolam</a> 0.25 to 0.5 mg) usually reduce anxiety without leading to respiratory depression. If tachypnea is primarily due to pain, a small dose of an opioid (eg, <a class="drug drug_general" data-topicid="8441" href="/d/drug information/8441.html" rel="external">fentanyl</a> 25 to 50 mcg) may be used for premedication instead of a sedative. Combinations of sedatives and opioids should be used with caution to avoid respiratory depression [<a href="#rid35">35</a>]. Monitoring (eg, pulse oximetry) is continuous during and after administration of any preoperative sedative or opioid so that respiratory depression can be immediately recognized and treated.</p><p class="headingAnchor" id="H396785556"><span class="h1">CHOICE OF ANESTHETIC TECHNIQUE</span><span class="headingEndMark"> — </span>The choice of anesthetic technique (monitored anesthesia care [MAC], neuraxial anesthesia, peripheral nerve blocks, or general anesthesia) should be guided primarily by the requirements of the procedure, and by surgeon and patient preferences. Notably, bronchospasm may develop at any time in the perioperative period during any surgical procedure, regardless of which anesthetic technique is selected.</p><p>For most patients with COPD, we suggest MAC, neuraxial anesthesia, or another regional anesthetic technique (eg, peripheral nerve block) when appropriate for the planned procedure, to avoid airway stimulation due to laryngoscopy and endotracheal intubation or insertion of other airway devices.</p><p>However, general anesthesia is typically preferred for patients with more severe COPD (eg, baseline dyspnea with minimal exertion, inability to lie supine, persistent coughing) and for procedures of prolonged duration. Also, general anesthesia is necessary for performance of many surgical procedures (eg, abdominal laparoscopic procedures, thoracic procedures, or surgical incisions involving the head, neck, or multiple extremities), and for those who do not consent to a regional anesthetic technique. </p><p class="headingAnchor" id="H4206192957"><span class="h1">INTRAOPERATIVE MANAGEMENT</span></p><p class="headingAnchor" id="H122018493"><span class="h2">Monitored anesthesia care</span><span class="headingEndMark"> — </span>Monitored anesthesia care (MAC), with or without judicious sedation or a concomitant regional anesthetic technique, is often selected for patients with COPD undergoing minor procedures. (See  <a class="medical medical_review" href="/d/html/94529.html" rel="external">"Monitored anesthesia care in adults"</a>.)</p><p>Since COPD patients are typically older, they may be particularly sensitive to the respiratory depressant effects of individual sedative or opioid agents and combinations of these agents. Therefore, small, incremental doses are administered as necessary, with continuous monitoring of oxygen saturation and end-tidal<sub> </sub>carbon dioxide (EtCO<sub>2</sub>). (See  <a class="medical medical_review" href="/d/html/94529.html" rel="external">"Monitored anesthesia care in adults", section on 'Drugs used for sedation and analgesia for monitored anesthesia care'</a> and  <a class="medical medical_review" href="/d/html/14931.html" rel="external">"Anesthesia for the older adult", section on 'Selection and dosing of anesthetic agents'</a>.)</p><p>Oxygen saturation should be kept as close as possible to preoperative values during MAC techniques. If necessary, supplemental oxygen is administered to maintain saturation 88 to 92 percent. Administration of a high oxygen percentage in a spontaneously breathing COPD patient increases risk of CO<sub>2</sub> retention and may not enhance tissue oxygenation [<a href="#rid36">36</a>]. The resultant hypoventilation and interference with hypoxic pulmonary vasoconstriction leads to worsening ventilation/perfusion (V/Q) mismatch [<a href="#rid36">36</a>]. (See  <a class="medical medical_review" href="/d/html/1458.html" rel="external">"The evaluation, diagnosis, and treatment of the adult patient with acute hypercapnic respiratory failure", section on 'Titration of oxygen'</a> and  <a class="medical medical_review" href="/d/html/1461.html" rel="external">"COPD exacerbations: Management", section on 'Oxygen therapy'</a>.)</p><p class="headingAnchor" id="H144230942"><span class="h2">Neuraxial anesthesia</span><span class="headingEndMark"> — </span>Use of neuraxial techniques (ie, spinal, epidural, and combined spinal-epidural) as the primary anesthetic for appropriate surgical procedures avoids airway manipulation as a potential cause of bronchospasm. Theoretical concerns include paralysis of accessory muscles of breathing with midthoracic or higher levels of neuraxial anesthesia, alteration of the ratio of parasympathetic to sympathetic tone due to sympathectomy (theoretically favoring an increase in bronchomotor tone), and arterial hypotension due to sympathectomy. However, these concerns have not been supported by clinical outcomes [<a href="#rid37">37-46</a>]. (See  <a class="medical medical_review" href="/d/html/89517.html" rel="external">"Overview of neuraxial anesthesia"</a>.)</p><p>Neuraxial analgesic techniques (eg, epidural) may also be used (with or without intraoperative general anesthesia) to provide multimodal postoperative analgesia, particularly if a large thoracic or abdominal surgical incision is planned. Compared with general anesthesia alone with postoperative use of systemic opioid analgesia, neuraxial analgesia provides superior postoperative pain control and facilitates deep breathing and ambulation [<a href="#rid46">46</a>].</p><p>In a review of surgical patients with known COPD in the Surgical Care Improvement Project database, the investigators used propensity matching to compare general anesthesia (n = 2644 patients) with regional anesthesia (epidural, spinal, or peripheral nerve block; n = 2644 patients) [<a href="#rid37">37</a>]. Those receiving regional anesthesia had a lower incidence of postoperative pneumonia (2.3 versus 3.3 percent, difference of 1 percent, 95% CI 0.09-1.88), unplanned postoperative reintubation (1.8 versus 2.6 percent, difference of 0.8 percent, 95% CI 0.04-1.62), and prolonged intubation &gt;48 hours (0.9 versus 2.1 percent, difference of 1.2 percent, 95% CI 0.51-1.84). Similarly, in a cohort study in 541 consecutive patients with known COPD who were undergoing major abdominal surgery, the investigators noted a reduction in pneumonia (11 versus 16 percent, odds ratio [OR] 0.6, 95% CI 0.3-0.9) and mortality (5 versus 9 percent, OR 0.6, 95% CI 0.3-1.2) in those receiving epidural anesthesia in addition to general anesthesia (n = 324), compared with general anesthesia alone (n = 217) [<a href="#rid38">38</a>]. In another study, propensity matching was used to ensure an equal incidence of COPD (24 percent) in 452 patients receiving neuraxial anesthesia and 904 receiving general anesthesia for lower extremity revascularization [<a href="#rid47">47</a>]. Less need for prolonged mechanical ventilation ≥48 hours was noted after neuraxial anesthesia (0.2 versus 2.4 percent). Several meta-analyses of unselected patients undergoing a variety of surgical procedures have reported a significantly lower incidence of respiratory complications when neuraxial anesthesia/analgesia was administered during the perioperative period compared with general anesthesia alone, as discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/6970.html" rel="external">"Strategies to reduce postoperative pulmonary complications in adults", section on 'Anesthetic technique'</a>.)</p><p>Noninvasive ventilation (NIV) may be effective during neuraxial anesthesia to reverse hypoventilation induced by oversedation or inadvertent spread of local anesthetic to higher dermatomes [<a href="#rid48">48</a>]. Similarly, NIV may be employed to treat respiratory distress in the post-anesthesia care unit, and may decrease the need for reintubation in COPD patients. (See <a class="local">'Management of postanesthesia care'</a> below.)</p><p class="headingAnchor" id="H144231109"><span class="h2">Regional and peripheral nerve blocks</span><span class="headingEndMark"> — </span>Regional or peripheral nerve blocks may be appropriate in patients with COPD if the surgical site is peripheral (eg, ophthalmic or extremity procedures) and the planned procedure is of short to moderate duration [<a href="#rid37">37,43</a>]. As with neuraxial anesthesia, airway manipulation is avoided. (See  <a class="medical medical_review" href="/d/html/397.html" rel="external">"Overview of peripheral nerve blocks"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Transverse abdominis plane block</strong> – Preoperative or postoperative transversus abdominus plane and/or rectus sheath blocks have also known to be helpful adjuncts for postoperative pain management [<a href="#rid49">49</a>]. (See  <a class="medical medical_review" href="/d/html/121447.html" rel="external">"Abdominal nerve block techniques", section on 'Rectus sheath block'</a> and  <a class="medical medical_review" href="/d/html/122399.html" rel="external">"Transversus abdominis plane (TAP) blocks procedure guide"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Brachial plexus blocks</strong> – Some brachial plexus blocks for upper extremity surgery (eg, interscalene block, supraclavicular block) paralyze the ipsilateral hemidiaphragm by blocking the phrenic nerve, resulting in a 25 percent reduction of forced vital capacity (FVC) [<a href="#rid50">50-52</a>]. This effect may last for many hours, and may not be tolerated in patients with severe or symptomatic COPD (particularly if the larger right lung is affected). Use of an ultrasound-guided technique to facilitate more accurate delivery of smaller doses of local anesthetic may reduce the incidence of hemidiaphragmatic paralysis, but this adverse side effect cannot be predictably avoided [<a href="#rid50">50</a>]. (See  <a class="medical medical_review" href="/d/html/100069.html" rel="external">"Upper extremity nerve blocks: Techniques"</a>.)</p><p></p><p class="headingAnchor" id="H406254208"><span class="h2">General anesthesia</span></p><p class="headingAnchor" id="H85183324"><span class="h3">Induction and airway management</span><span class="headingEndMark"> — </span>A primary goal of anesthetic induction is to minimize the risk of a bronchoconstrictive response to airway manipulation, similar to induction in patients with asthma. This risk is lower with mask ventilation or insertion of a laryngeal mask airway (LMA) compared with endotracheal intubation, although LMAs have not been specifically studied in patients with COPD [<a href="#rid53">53</a>]. However, intubation is necessary for some patients due to procedure-related or patient-related factors. (See  <a class="medical medical_review" href="/d/html/94358.html" rel="external">"Anesthesia for adult patients with asthma", section on 'Airway management'</a> and  <a class="medical medical_review" href="/d/html/91218.html" rel="external">"Airway management for induction of general anesthesia", section on 'Choice of airway device'</a>.)</p><p>Most adults prefer intravenous (IV) induction of anesthesia because of the unpleasantly pungent odor of most potent volatile agents [<a href="#rid54">54</a>] (see  <a class="medical medical_review" href="/d/html/94135.html" rel="external">"Induction of general anesthesia: Overview", section on 'Intravenous anesthetic induction'</a>). Furthermore, IV induction is faster than inhalation induction. In COPD patients, inhalation induction can be further delayed due to ventilation/perfusion (V/Q) mismatch causing anesthetic tension differences between end-tidal gas and arterial blood uptake [<a href="#rid55">55</a>].</p><p class="bulletIndent1">Either <a class="drug drug_general" data-topicid="9826" href="/d/drug information/9826.html" rel="external">propofol</a> or <a class="drug drug_general" data-topicid="8588" href="/d/drug information/8588.html" rel="external">ketamine</a> is suitable as the primary agent for IV induction of anesthesia in patients with COPD. <a class="drug drug_general" data-topicid="8428" href="/d/drug information/8428.html" rel="external">Etomidate</a> is less desirable since it increases airway resistance and is associated with adrenal gland dysfunction [<a href="#rid56">56,57</a>]. Details regarding choice of induction agent are discussed separately. (See  <a class="medical medical_review" href="/d/html/94358.html" rel="external">"Anesthesia for adult patients with asthma", section on 'Induction of anesthesia'</a> and  <a class="medical medical_review" href="/d/html/94533.html" rel="external">"General anesthesia: Intravenous induction agents"</a>.)</p><p></p><p>If endotracheal intubation is planned, adjuvant medications, typically an opioid and/or <a class="drug drug_general" data-topicid="9558" href="/d/drug information/9558.html" rel="external">lidocaine</a>, as well as a neuromuscular blocking agent (NMBA) are administered together with the primary induction agent. (See  <a class="medical medical_review" href="/d/html/94533.html" rel="external">"General anesthesia: Intravenous induction agents", section on 'Adjuvant agents'</a>.)</p><p>When an inhalation induction technique is preferred, <a class="drug drug_general" data-topicid="9887" href="/d/drug information/9887.html" rel="external">sevoflurane</a> is typically selected since it has the most pronounced bronchodilatory properties of the available agents [<a href="#rid19">19,58</a>] (see  <a class="medical medical_review" href="/d/html/94135.html" rel="external">"Induction of general anesthesia: Overview", section on 'Inhalation anesthetic induction'</a>). <a class="drug drug_general" data-topicid="8891" href="/d/drug information/8891.html" rel="external">Desflurane</a> is avoided because its extreme pungency may increase secretions and cause coughing, laryngospasm, and/or bronchospasm during induction, particularly in current smokers, and it may increase airway resistance [<a href="#rid58">58-60</a>]. (See  <a class="medical medical_review" href="/d/html/94358.html" rel="external">"Anesthesia for adult patients with asthma", section on 'Induction of anesthesia'</a> and  <a class="medical medical_review" href="/d/html/114826.html" rel="external">"Inhalation anesthetic agents: Clinical effects and uses", section on 'Induction of general anesthesia'</a>.)</p><p class="headingAnchor" id="H406254308"><span class="h3">Maintenance of anesthesia</span><span class="headingEndMark"> — </span>Similar to patients with asthma, we typically select a potent volatile inhalation agent with bronchodilatory properties (eg, <a class="drug drug_general" data-topicid="9887" href="/d/drug information/9887.html" rel="external">sevoflurane</a>, <a class="drug drug_general" data-topicid="8992" href="/d/drug information/8992.html" rel="external">isoflurane</a>) as the primary agent to maintain general anesthesia [<a href="#rid19">19,58</a>], supplemented with small doses of an opioid (eg, <a class="drug drug_general" data-topicid="8441" href="/d/drug information/8441.html" rel="external">fentanyl</a>) to deepen anesthesia or suppress the cough reflex. For some cases, total intravenous anesthesia (TIVA) may be preferred and is a reasonable alternative. For example, TIVA is useful for patients with large bullous emphysema to avoid the hypoxemia that may occur due to interference with hypoxic pulmonary vasoconstriction caused by volatile agents. In such cases, <a class="drug drug_general" data-topicid="10086" href="/d/drug information/10086.html" rel="external">nitrous oxide</a> (N<sub>2</sub>O) is also avoided, as N<sub>2</sub>O may cause bullae expansion and rupture as gas is trapped [<a href="#rid61">61</a>]. (See  <a class="medical medical_review" href="/d/html/94358.html" rel="external">"Anesthesia for adult patients with asthma", section on 'Maintenance of anesthesia'</a>.)</p><p>If necessary, a NMBA is administered to facilitate surgical exposure. We suggest using agents that do not release appreciable amounts of histamine, such as <a class="drug drug_general" data-topicid="9872" href="/d/drug information/9872.html" rel="external">rocuronium</a>, <a class="drug drug_general" data-topicid="10041" href="/d/drug information/10041.html" rel="external">vecuronium</a>, or <a class="drug drug_general" data-topicid="9270" href="/d/drug information/9270.html" rel="external">cisatracurium</a>, rather than <a class="drug drug_general" data-topicid="8973" href="/d/drug information/8973.html" rel="external">atracurium</a> or mivacurium. (See  <a class="medical medical_review" href="/d/html/94535.html" rel="external">"Clinical use of neuromuscular blocking agents in anesthesia"</a>.)</p><p class="headingAnchor" id="H85183455"><span class="h3">Mechanical ventilation</span><span class="headingEndMark"> — </span>Either a volume- or pressure-limited mode of ventilation can be used, but optimal tidal volume and positive end-expiratory pressure (PEEP) must be maintained.</p><p>Lung-protective ventilation for the patient with COPD should include the following (see  <a class="medical medical_review" href="/d/html/93386.html" rel="external">"Mechanical ventilation during anesthesia in adults", section on 'Lung protective ventilation during anesthesia'</a>) [<a href="#rid30">30</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Controlled ventilation with reduced tidal volume (6 to 8 mL/kg predicted body weight)  (<a class="graphic graphic_table graphicRef87507" href="/d/graphic/87507.html" rel="external">table 5</a> and <a class="graphic graphic_table graphicRef87147" href="/d/graphic/87147.html" rel="external">table 6</a>). Reducing tidal volume helps prevent air trapping and avoids high driving pressure and high plateau pressure (eg, &gt;15 cm H<sub>2</sub>O), thereby minimizing risk of barotrauma. However, reducing tidal volume may decrease minute ventilation, potentially causing hypercapnia and hypoxemia. This can be partially offset by a cautious increase in respiratory rate, as long as expiratory time remains adequate for complete exhalation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Reduced respiratory rate (8 to 10 breaths/minute [bpm]) with longer expiratory time (eg, inspiratory-to-expiratory [I:E] ratio of 1:3 to 1:4) to reduce air trapping. We typically do not exceed 10 bpm. Some degree of hypercapnia is acceptable in patients without any specific contraindication for hypercapnia (eg, elevated intracranial pressure), but adequate oxygenation and a pH ≥7.25 should be maintained. (See  <a class="medical medical_review" href="/d/html/1645.html" rel="external">"Permissive hypercapnia during mechanical ventilation in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cautious use of PEEP, initially at 5 cmH<sub>2</sub>O to keep the small airways open, with continuous monitoring for signs of hyperinflation. (See  <a class="medical medical_review" href="/d/html/1632.html" rel="external">"Invasive mechanical ventilation in acute respiratory failure complicating chronic obstructive pulmonary disease", section on 'Dynamic hyperinflation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Maintenance of driving pressure ≤15 cmH<sub>2</sub>O. At the initial settings for tidal volume and PEEP noted above, if driving pressure is &gt;15 cm H<sub>2</sub>O we increase PEEP cautiously in an attempt to recruit alveoli and improve compliance  (<a class="graphic graphic_algorithm graphicRef128233" href="/d/graphic/128233.html" rel="external">algorithm 3</a>). There is no absolute plateau pressure above or below which baro- or volutrauma does or does not occur but, in general, the higher this pressure, the greater the risk of barotrauma; plateau pressures above 35 cm H<sub>2</sub>O carry the highest risk.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Monitoring for a phenomenon known as breath-stacking (ie, dynamic hyperinflation, auto-PEEP, air-trapping), which may occur during mechanical ventilation of patients with COPD, and can cause high peak airway pressures or cause a sudden decrease in systemic blood pressure  (<a class="graphic graphic_figure graphicRef78052" href="/d/graphic/78052.html" rel="external">figure 2</a>) (see  <a class="medical medical_review" href="/d/html/1632.html" rel="external">"Invasive mechanical ventilation in acute respiratory failure complicating chronic obstructive pulmonary disease", section on 'Dynamic hyperinflation'</a>). Signs of breath-stacking include increasing peak airway pressure, decreasing exhaled volume, and hypotension. Failure of the flow tracing to return to baseline before the next breath on flow-volume loops also indicates persistent end-expiratory flow and likely auto-PEEP [<a href="#rid62">62</a>]. When breath stacking is suspected, transiently disconnecting (eg, &lt;1 minute) the anesthesia circuit can be diagnostic and therapeutic. Auto-PEEP (also called intrinsic PEEP) improves immediately (typically in less than one minute) when the anesthesia mask is transiently lifted from the face, or the breathing circuit is transiently disconnected.</p><p></p><p class="bulletIndent1">Dynamic hyperinflation is subsequently managed by administering bronchodilator medication, reducing minute ventilation (ie, reducing respiratory rate and tidal volume), and sometimes by increasing inspiratory flow to increase expiratory time. If auto-PEEP (intrinsic PEEP) persists, it may be helpful to cautiously add applied PEEP (also called extrinsic PEEP) at levels below 80 percent of the measured auto-PEEP; close observation is needed as worsening of dynamic hyperinflation may occur.</p><p></p><p class="bulletIndent1">Notably, dynamic hyperinflation creates a risk for pneumothorax in COPD patients with subpleural bullae. Like dynamic hyperinflation, pneumothorax may present as sudden hypotension and worsening oxygenation. However, the hypotension does not resolve when the ventilator circuit is disconnected from the endotracheal tube. Emergency treatment of tension pneumothorax involves needle decompression followed by surgical chest tube placement. (See  <a class="medical medical_review" href="/d/html/7816.html" rel="external">"Thoracostomy tubes and catheters: Indications and tube selection in adults and children", section on 'Tension pneumothorax'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Adjusting fraction of inspired oxygen (FiO<sub>2</sub>) to the lowest level required to target a pulse oxygen saturation of 88 to 92 percent.</p><p></p><p>Details regarding lung-protective mechanical ventilation in patients with COPD are available in other topics:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/93386.html" rel="external">"Mechanical ventilation during anesthesia in adults", section on 'Lung protective ventilation during anesthesia'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/94358.html" rel="external">"Anesthesia for adult patients with asthma", section on 'Controlled ventilation during anesthesia'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/1632.html" rel="external">"Invasive mechanical ventilation in acute respiratory failure complicating chronic obstructive pulmonary disease", section on 'Ventilator settings'</a>.)</p><p></p><p class="headingAnchor" id="H406254433"><span class="h3">Emergence</span><span class="headingEndMark"> — </span>Bronchoconstriction may develop as anesthetic depth is lightened at the end of the procedure. An aerosolized or nebulized bronchodilator may be administered prophylactically shortly before emergence if more than two hours have elapsed since the last dose. Patients with COPD may benefit from treatment with an aerosolized or nebulized bronchodilator shortly before emergence from general anesthesia if increases in airway pressure or resistance are observed. (See  <a class="medical medical_review" href="/d/html/94358.html" rel="external">"Anesthesia for adult patients with asthma", section on 'Emergence from anesthesia'</a>.)</p><p>End-tidal concentration of the inhalation agent is ideally brought to zero, although elimination of anesthetic agent by exhalation may be prolonged in COPD patients due to ventilation/perfusion (V/Q) mismatch and dead-space ventilation [<a href="#rid20">20</a>]. The arterial tension of carbon dioxide (PaCO<sub>2</sub>) should be kept as close as possible to preoperative values during and after emergence. </p><p>Complete reversal of neuromuscular blockade at the conclusion of the surgical procedure is particularly important in patients with COPD [<a href="#rid63">63-65</a>] (see  <a class="medical medical_review" href="/d/html/94537.html" rel="external">"Emergence from general anesthesia", section on 'Assess and reverse effects of neuromuscular blocking agents'</a>). Residual neuromuscular blockade can cause upper airway obstruction, diaphragmatic dysfunction, and impaired mucociliary clearance leading to hypoventilation and pulmonary complications in the immediate postoperative period. (See  <a class="medical medical_review" href="/d/html/94535.html" rel="external">"Clinical use of neuromuscular blocking agents in anesthesia", section on 'Reversal of neuromuscular block'</a>.)</p><p class="headingAnchor" id="H22657715"><span class="h1">MANAGEMENT OF POSTANESTHESIA CARE</span><span class="headingEndMark"> — </span>Management in the immediate postoperative period includes resumption of bronchodilator therapy (and inhaled glucocorticoids if part of baseline regimen) [<a href="#rid17">17,28,33</a>], use of incentive spirometry, and encouraging early ambulation. Pain control should be sufficient to facilitate deep breathing and mobilization, but hypoventilation should be avoided. Use of epidural opioids rather than with systemic opioids decreases risk of atelectasis and pulmonary infection [<a href="#rid66">66</a>]. (See  <a class="medical medical_review" href="/d/html/6970.html" rel="external">"Strategies to reduce postoperative pulmonary complications in adults", section on 'Postoperative strategies'</a> and  <a class="medical medical_review" href="/d/html/89518.html" rel="external">"Epidural and combined spinal-epidural anesthesia: Techniques", section on 'Choice of epidural drugs'</a>.)</p><p>Patients with COPD may develop bronchospasm or hypoventilation due to residual sedation caused by inhalation agents or opioids, or due to weakness caused by neuromuscular blocking agents (NMBAs) during the immediate postoperative period. Depressed ability to cough or breathe deeply due to somnolence, muscle weakness, pain, and/or opioid-induced respiratory depression can lead to retention of secretions, atelectasis, hypoxemia, and eventual development of bronchitis, pneumonia, and respiratory failure necessitating prolonged mechanical ventilation [<a href="#rid17">17</a>]. (See  <a class="medical medical_review" href="/d/html/94358.html" rel="external">"Anesthesia for adult patients with asthma", section on 'Postoperative management'</a> and  <a class="medical medical_review" href="/d/html/94348.html" rel="external">"Respiratory problems in the post-anesthesia care unit (PACU)"</a>.)</p><p>Noninvasive ventilation (NIV) should be readily available in the post-anesthesia care unit to treat respiratory distress in COPD patients without contraindications: this may decrease the need for reintubation [<a href="#rid67">67</a>]. Reintubation, atelectasis, pneumonia, and prolonged controlled ventilation may be avoided by initiating NIV as soon as the patient has any signs or symptoms of respiratory distress, rather than waiting until there is definitive evidence of respiratory failure  (<a class="graphic graphic_table graphicRef51201" href="/d/graphic/51201.html" rel="external">table 7</a>) [<a href="#rid68">68-70</a>]. High-flow nasal cannula (HFNC) oxygen may be helpful in patients at risk of acute hypoxemic respiratory failure post-extubation, although use in COPD patients has not been rigorously studied [<a href="#rid71">71</a>]. Details regarding initiation and management of NIV are discussed separately. (See  <a class="medical medical_review" href="/d/html/1636.html" rel="external">"Noninvasive ventilation in adults with acute respiratory failure: Benefits and contraindications"</a> and  <a class="medical medical_review" href="/d/html/94348.html" rel="external">"Respiratory problems in the post-anesthesia care unit (PACU)"</a>.)</p><p class="headingAnchor" id="H4016324036"><span class="h1">SPECIAL POPULATIONS</span></p><p class="headingAnchor" id="H3967210641"><span class="h2">Laparoscopic surgery</span><span class="headingEndMark"> — </span>Abdominal laparoscopic surgery is associated with less postoperative pain and does not reduce functional residual capacity (FRC) as much as open abdominal surgery [<a href="#rid8">8</a>]. However, laparoscopic surgery does not decrease the incidence of postoperative pulmonary complications in patients with COPD [<a href="#rid16">16</a>].</p><p>Absorption of the carbon dioxide (CO<sub>2</sub>) gas used to create the pneumoperitoneum necessary for laparoscopic surgery may cause significant hypercapnia and respiratory acidosis, particularly in patients with COPD [<a href="#rid72">72</a>]. Treatment of hypercapnia with the usual compensatory adjustments of mechanical ventilation (eg, a faster respiratory rate) may not be possible due to the need for a prolonged expiratory time. In addition, pneumoperitoneum increases intraabdominal pressure, which may cause cephalad shift of the diaphragm, increased intrathoracic pressure, worsening V/Q mismatch, and hypoxemia. These changes are largely reversed after desufflation of the abdomen [<a href="#rid72">72-74</a>]. In some cases, intermittent desufflation and/or lower insufflation pressures may be necessary to minimize the adverse effects of pneumoperitoneum in some patients with severe COPD [<a href="#rid13">13,72</a>].</p><p class="headingAnchor" id="H1874570801"><span class="h2">Pulmonary resection</span><span class="headingEndMark"> — </span>Management of patients with pulmonary abnormalities (including COPD) during pulmonary resection is discussed in a separate topic. (See  <a class="medical medical_review" href="/d/html/94261.html" rel="external">"Anesthesia for open pulmonary resection"</a>.)</p><p class="headingAnchor" id="H4099338002"><span class="h2">Emergency surgery</span><span class="headingEndMark"> — </span>Induction of anesthesia for emergency procedures requiring general anesthesia balances the need for rapid control of the airway with avoidance of bronchospasm during endotracheal intubation. Even in emergency surgery, there is usually time to administer preoperative inhaled bronchodilators. Details are discussed separately. (See  <a class="medical medical_review" href="/d/html/94358.html" rel="external">"Anesthesia for adult patients with asthma", section on 'Emergency surgery'</a>.)</p><p class="headingAnchor" id="H4268864772"><span class="h2">Patients with increased intracranial pressure</span><span class="headingEndMark"> — </span>Mechanical ventilation in patients with increased intracranial pressure (ICP) can be especially challenging since hyperventilation to decrease ICP may result in hyperinflation and barotrauma in a patient with COPD. Also, use of volatile anesthetics agents may decrease cerebral perfusion pressure (CPP) and further increase ICP. Anesthetic management strategies are discussed separately. (See  <a class="medical medical_review" href="/d/html/94358.html" rel="external">"Anesthesia for adult patients with asthma", section on 'Asthmatic patients with increased intracranial pressure'</a> and  <a class="medical medical_review" href="/d/html/1659.html" rel="external">"Evaluation and management of elevated intracranial pressure in adults", section on 'Hyperventilation'</a>.)</p><p class="headingAnchor" id="H144232091"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Preanesthesia consultation and optimization </strong>–<strong> </strong>Preanesthesia consultation for patients with chronic obstructive pulmonary disease (COPD) includes assessment of whether pulmonary function is optimal. Elective surgery is postponed in patients with signs and symptoms of COPD exacerbation or active upper respiratory infection, with referral to primary care or pulmonary medicine. Typically, inhaled bronchodilators (eg, beta-adrenergic agonists and anticholinergic agents) and a brief course of systemic glucocorticoid therapy are prescribed, as well as antibiotics when indicated. The time needed for patients to return to baseline after a COPD exacerbation varies; thus, duration of postponement is individualized. (See <a class="local">'Preanesthesia consultation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Risk factors for pulmonary complications </strong>–<strong> </strong>Concerns regarding general anesthesia include bronchospasm due to mechanical stimulation of the airway during laryngoscopy, endotracheal intubation or extubation, airway suctioning, inhalation of cold anesthetic gases, or, rarely, pulmonary aspiration. Other concerns include dynamic hyperinflation due to breath stacking during controlled ventilation, atelectasis resulting from reduction in functional residual capacity (FRC), and residual sedation leading to hypoventilation. (See <a class="local">'Anesthetic factors'</a> above and <a class="local">'Procedure-related factors'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Preoperative medication management </strong>–<strong> </strong>Inhaled beta-agonist and muscarinic antagonist bronchodilators, as well as inhaled glucocorticoids, are continued in the perioperative period, including the usual dose on the morning of surgery, with resumption shortly after surgery. For patients with a high likelihood of adrenal suppression, supplemental glucocorticoids are given in accordance with the magnitude of the anticipated stress of the procedure  (<a class="graphic graphic_table graphicRef69479" href="/d/graphic/69479.html" rel="external">table 4</a>). Notably, the usual morning oral dose of glucocorticoid is always administered, regardless of whether additional glucocorticoid will be given just prior to the procedure. (See <a class="local">'Perioperative medication management'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Choice of anesthetic technique </strong>–<strong> </strong>Requirements for the surgical procedure and patient preferences are the primary factors guiding selection of anesthetic technique. General anesthesia is necessary for performance of many surgical procedures (eg, abdominal laparoscopic procedures, thoracic procedures, or surgical incisions involving the head, neck, or multiple extremities), and is typically selected for procedures of long duration. Monitored anesthesia care (MAC), neuraxial anesthesia, or a peripheral nerve block is selected when appropriate for the planned procedure to avoid laryngoscopy and endotracheal intubation in patients with COPD. However, these techniques are not suitable for patients who do not consent or for those with extreme anxiety, severe dyspnea when lying flat, or chronic coughing if the surgeon requires absence of movement. (See <a class="local">'Choice of anesthetic technique'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Neuraxial anesthesia – </strong>For consenting patients with COPD undergoing appropriate surgical procedures, we suggest a neuraxial anesthetic technique (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>), which provides superior perioperative analgesia and decreases the risk of pneumonia and respiratory failure. (See <a class="local">'Neuraxial anesthesia'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Regional anesthesia </strong>–<strong> </strong>A peripheral nerve block may be appropriate if the surgical site is peripheral and the planned procedure is of short to moderate duration. However, some brachial plexus blocks for upper extremity surgery (eg, interscalene block, supraclavicular block) paralyze the ipsilateral diaphragm by blocking the phrenic nerve, an effect may last for many hours, and may not be tolerated in patients with severe or symptomatic COPD. (See <a class="local">'Regional and peripheral nerve blocks'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Monitored anesthesia care </strong>–<strong> </strong>During MAC techniques, only small, incremental doses of anesthetic agents are administered as necessary. Oxygen saturation and end-tidal carbon dioxide (EtCO<sub>2</sub>) are continuously monitored, and supplemental oxygen is administered to maintain saturation 88 to 92 percent if necessary. (See  <a class="medical medical_review" href="/d/html/94529.html" rel="external">"Monitored anesthesia care in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>General anesthesia</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Induction </strong>–<strong> </strong>For general anesthesia, most adults prefer intravenous (IV) induction, which is faster than inhalation induction, particularly in COPD patients due to ventilation/perfusion (V/Q) mismatch; either <a class="drug drug_general" data-topicid="9826" href="/d/drug information/9826.html" rel="external">propofol</a> or <a class="drug drug_general" data-topicid="8588" href="/d/drug information/8588.html" rel="external">ketamine</a> is suitable. The risk of bronchoconstriction is lower with mask ventilation or insertion of a laryngeal mask airway (LMA) compared with endotracheal intubation. (See <a class="local">'Induction and airway management'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Maintenance</strong></p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Agent selection </strong>–<strong> </strong>We typically select a potent volatile inhalation agent with bronchodilatory properties (eg, <a class="drug drug_general" data-topicid="9887" href="/d/drug information/9887.html" rel="external">sevoflurane</a>, <a class="drug drug_general" data-topicid="8992" href="/d/drug information/8992.html" rel="external">isoflurane</a>) as the primary agent for maintenance of anesthesia, supplemented with small doses of an opioid (eg, <a class="drug drug_general" data-topicid="8441" href="/d/drug information/8441.html" rel="external">fentanyl</a>) to deepen anesthesia or suppress the cough reflex. Total intravenous anesthesia (TIVA) is a reasonable alternative. (See <a class="local">'Maintenance of anesthesia'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Management of ventilation </strong>– We employ lung-protective ventilation during general anesthesia  (<a class="graphic graphic_algorithm graphicRef128233" href="/d/graphic/128233.html" rel="external">algorithm 3</a>). Breath stacking (ie, dynamic hyperinflation, auto-positive end-expiratory pressure [PEEP]) may occur  (<a class="graphic graphic_figure graphicRef78052" href="/d/graphic/78052.html" rel="external">figure 2</a>), causing a sudden decrease in systemic blood pressure which improves immediately when the anesthesia breathing circuit is transiently disconnected. Tension pneumothorax due to rupture of subpleural bullae also causes sudden hypotension, but without resolution when the anesthesia circuit is disconnected. (See <a class="local">'Mechanical ventilation'</a> above and  <a class="medical medical_review" href="/d/html/93386.html" rel="external">"Mechanical ventilation during anesthesia in adults", section on 'Lung protective ventilation during anesthesia'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Emergence </strong>–<strong> </strong>Since bronchoconstriction may occur as anesthetic depth is lightened, an aerosolized or nebulized bronchodilator may be administered shortly before emergence if more than two hours have elapsed since the last dose. Complete reversal of neuromuscular blockade is particularly important to avoid upper airway obstruction, diaphragmatic dysfunction, and impaired mucociliary clearance leading to hypoventilation in the immediate postoperative period. (See <a class="local">'Emergence'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Postanesthesia care </strong>–<strong> </strong>Management in the immediate postoperative period includes resumption of bronchodilator therapy (and inhaled glucocorticoids if part of baseline regimen), use of incentive spirometry, and early ambulation. Pain control should be sufficient to facilitate deep breathing and mobilization, but hypoventilation is avoided. Noninvasive ventilation (NIV) should be readily available to treat respiratory distress and potentially avoid reintubation in patients without contraindications  (<a class="graphic graphic_table graphicRef51201" href="/d/graphic/51201.html" rel="external">table 7</a>). (See <a class="local">'Management of postanesthesia care'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Fields AC, Divino CM. Surgical outcomes in patients with chronic obstructive pulmonary disease undergoing abdominal operations: An analysis of 331,425 patients. Surgery 2016; 159:1210.</a></li><li><a class="nounderline abstract_t">Johnson AP, Altmark RE, Weinstein MS, et al. Predicting the Risk of Postoperative Respiratory Failure in Elective Abdominal and Vascular Operations Using the National Surgical Quality Improvement Program (NSQIP) Participant Use Data File. Ann Surg 2017; 266:968.</a></li><li><a class="nounderline abstract_t">Canet J, Gallart L, Gomar C, et al. Prediction of postoperative pulmonary complications in a population-based surgical cohort. Anesthesiology 2010; 113:1338.</a></li><li><a class="nounderline abstract_t">Smith MC, Wrobel JP. Epidemiology and clinical impact of major comorbidities in patients with COPD. Int J Chron Obstruct Pulmon Dis 2014; 9:871.</a></li><li><a class="nounderline abstract_t">Sin DD, Man SF. Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc Am Thorac Soc 2005; 2:8.</a></li><li><a class="nounderline abstract_t">Fleisher LA, Fleischmann KE, Auerbach AD, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014; 130:2215.</a></li><li class="breakAll">Ferguson MK. Pulmonary Physiologic Assessment of Operative Risk. In: General Thoracic Surgery, 7th, Shields TW, LoCiero J, Reed CE, Feins RH (Eds), Lippincott, Williams &amp; Wilkins, 2009. p.325.</li><li><a class="nounderline abstract_t">Joris J, Kaba A, Lamy M. Postoperative spirometry after laparoscopy for lower abdominal or upper abdominal surgical procedures. Br J Anaesth 1997; 79:422.</a></li><li><a class="nounderline abstract_t">Smetana GW, Lawrence VA, Cornell JE, American College of Physicians. Preoperative pulmonary risk stratification for noncardiothoracic surgery: systematic review for the American College of Physicians. Ann Intern Med 2006; 144:581.</a></li><li><a class="nounderline abstract_t">Rehder K. Postural changes in respiratory function. Acta Anaesthesiol Scand Suppl 1998; 113:13.</a></li><li><a class="nounderline abstract_t">Tanskanen P, Kyttä J, Randell T. The effect of patient positioning on dynamic lung compliance. Acta Anaesthesiol Scand 1997; 41:602.</a></li><li><a class="nounderline abstract_t">Pelosi P, Croci M, Calappi E, et al. The prone positioning during general anesthesia minimally affects respiratory mechanics while improving functional residual capacity and increasing oxygen tension. Anesth Analg 1995; 80:955.</a></li><li><a class="nounderline abstract_t">El-Shafie M, Ashraf M, Mahfouz M. Prone position in artificially ventilated chronic obstructive pulmonary disease patients assessment of lung mechani. Med J Cairo Univ 2010; 78:33.</a></li><li><a class="nounderline abstract_t">Mure M, Domino KB, Lindahl SG, et al. Regional ventilation-perfusion distribution is more uniform in the prone position. J Appl Physiol (1985) 2000; 88:1076.</a></li><li><a class="nounderline abstract_t">Gunnarsson L, Tokics L, Lundquist H, et al. Chronic obstructive pulmonary disease and anaesthesia: formation of atelectasis and gas exchange impairment. Eur Respir J 1991; 4:1106.</a></li><li><a class="nounderline abstract_t">Numata T, Nakayama K, Fujii S, et al. Risk factors of postoperative pulmonary complications in patients with asthma and COPD. BMC Pulm Med 2018; 18:4.</a></li><li><a class="nounderline abstract_t">Licker M, Schweizer A, Ellenberger C, et al. Perioperative medical management of patients with COPD. Int J Chron Obstruct Pulmon Dis 2007; 2:493.</a></li><li><a class="nounderline abstract_t">Bigatello L, Pesenti A. Respiratory Physiology for the Anesthesiologist. Anesthesiology 2019; 130:1064.</a></li><li><a class="nounderline abstract_t">Yamakage M, Iwasaki S, Namiki A. Guideline-oriented perioperative management of patients with bronchial asthma and chronic obstructive pulmonary disease. J Anesth 2008; 22:412.</a></li><li><a class="nounderline abstract_t">Dupont J, Tavernier B, Ghosez Y, et al. Recovery after anaesthesia for pulmonary surgery: desflurane, sevoflurane and isoflurane. Br J Anaesth 1999; 82:355.</a></li><li><a class="nounderline abstract_t">Milledge JS, Nunn JF. Criteria of fitness for anaesthesia in patients with chronic obstructive lung disease. Br Med J 1975; 3:670.</a></li><li><a class="nounderline abstract_t">Fermont JM, Bolton CE, Fisk M, et al. Risk assessment for hospital admission in patients with COPD; a multi-centre UK prospective observational study. PLoS One 2020; 15:e0228940.</a></li><li><a class="nounderline abstract_t">Lumb AB. Pre-operative respiratory optimisation: an expert review. Anaesthesia 2019; 74 Suppl 1:43.</a></li><li><a class="nounderline abstract_t">Lee AHY, Snowden CP, Hopkinson NS, Pattinson KTS. Pre-operative optimisation for chronic obstructive pulmonary disease: a narrative review. Anaesthesia 2021; 76:681.</a></li><li><a class="nounderline abstract_t">Silvanus MT, Groeben H, Peters J. Corticosteroids and inhaled salbutamol in patients with reversible airway obstruction markedly decrease the incidence of bronchospasm after tracheal intubation. Anesthesiology 2004; 100:1052.</a></li><li><a class="nounderline abstract_t">Walters JA, Tan DJ, White CJ, et al. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2014; :CD001288.</a></li><li><a class="nounderline abstract_t">Yousefzadeh A, Chung F, Wong DT, et al. Smoking Cessation: The Role of the Anesthesiologist. Anesth Analg 2016; 122:1311.</a></li><li><a class="nounderline abstract_t">Celli BR, MacNee W, ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23:932.</a></li><li><a class="nounderline abstract_t">Guan Z, Lv Y, Liu J, et al. Smoking Cessation Can Reduce the Incidence of Postoperative Hypoxemia After On-Pump Coronary Artery Bypass Grafting Surgery. J Cardiothorac Vasc Anesth 2016; 30:1545.</a></li><li><a class="nounderline abstract_t">Ball L, Almondo C, Pelosi P. Perioperative Lung Protection: General Mechanisms and Protective Approaches. Anesth Analg 2020; 131:1789.</a></li><li><a class="nounderline abstract_t">Valkenet K, van de Port IG, Dronkers JJ, et al. The effects of preoperative exercise therapy on postoperative outcome: a systematic review. Clin Rehabil 2011; 25:99.</a></li><li class="breakAll">Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease: 2024 Report. www.goldcopd.org (Accessed on November 16, 2023).</li><li><a class="nounderline abstract_t">Hong CM, Galvagno SM Jr. Patients with chronic pulmonary disease. Med Clin North Am 2013; 97:1095.</a></li><li><a class="nounderline abstract_t">Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187:347.</a></li><li><a class="nounderline abstract_t">Tverskoy M, Fleyshman G, Ezry J, et al. Midazolam-morphine sedative interaction in patients. Anesth Analg 1989; 68:282.</a></li><li><a class="nounderline abstract_t">Abdo WF, Heunks LM. Oxygen-induced hypercapnia in COPD: myths and facts. Crit Care 2012; 16:323.</a></li><li><a class="nounderline abstract_t">Hausman MS Jr, Jewell ES, Engoren M. Regional versus general anesthesia in surgical patients with chronic obstructive pulmonary disease: does avoiding general anesthesia reduce the risk of postoperative complications? Anesth Analg 2015; 120:1405.</a></li><li><a class="nounderline abstract_t">van Lier F, van der Geest PJ, Hoeks SE, et al. Epidural analgesia is associated with improved health outcomes of surgical patients with chronic obstructive pulmonary disease. Anesthesiology 2011; 115:315.</a></li><li><a class="nounderline abstract_t">Groeben H. Epidural anesthesia and pulmonary function. J Anesth 2006; 20:290.</a></li><li><a class="nounderline abstract_t">Panaretou V, Toufektzian L, Siafaka I, et al. Postoperative pulmonary function after open abdominal aortic aneurysm repair in patients with chronic obstructive pulmonary disease: epidural versus intravenous analgesia. Ann Vasc Surg 2012; 26:149.</a></li><li><a class="nounderline abstract_t">Groeben H, Schäfer B, Pavlakovic G, et al. Lung function under high thoracic segmental epidural anesthesia with ropivacaine or bupivacaine in patients with severe obstructive pulmonary disease undergoing breast surgery. Anesthesiology 2002; 96:536.</a></li><li><a class="nounderline abstract_t">Guay J, Choi P, Suresh S, et al. Neuraxial blockade for the prevention of postoperative mortality and major morbidity: an overview of Cochrane systematic reviews. Cochrane Database Syst Rev 2014; :CD010108.</a></li><li><a class="nounderline abstract_t">Barbosa FT, Jucá MJ, Castro AA, Cavalcante JC. Neuraxial anaesthesia for lower-limb revascularization. Cochrane Database Syst Rev 2013; :CD007083.</a></li><li><a class="nounderline abstract_t">Pöpping DM, Elia N, Van Aken HK, et al. Impact of epidural analgesia on mortality and morbidity after surgery: systematic review and meta-analysis of randomized controlled trials. Ann Surg 2014; 259:1056.</a></li><li><a class="nounderline abstract_t">Rodgers A, Walker N, Schug S, et al. Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials. BMJ 2000; 321:1493.</a></li><li><a class="nounderline abstract_t">Nishimori M, Low JH, Zheng H, Ballantyne JC. Epidural pain relief versus systemic opioid-based pain relief for abdominal aortic surgery. Cochrane Database Syst Rev 2012; :CD005059.</a></li><li><a class="nounderline abstract_t">Fereydooni A, O'Meara T, Popescu WM, et al. Use of neuraxial anesthesia for hybrid lower extremity revascularization is associated with reduced perioperative morbidity. J Vasc Surg 2020; 71:1296.</a></li><li><a class="nounderline abstract_t">Corcione N, Karim H, Mina B, et al. Non-invasive ventilation during surgery under neuraxial anaesthesia: a pathophysiological perspective on application and benefits and a systematic literature review. Anaesthesiol Intensive Ther 2019; 51:289.</a></li><li><a class="nounderline abstract_t">Xia J, Paul Olson TJ, Tritt S, et al. Comparison of preoperative versus postoperative transversus abdominis plane and rectus sheath block in patients undergoing minimally invasive colorectal surgery. Colorectal Dis 2020; 22:569.</a></li><li><a class="nounderline abstract_t">Sanchez M, Malhotra N, Lin L. End-stage pulmonary disease and brachial plexus regional anesthesia: their implications on perioperative pulmonary function. Semin Cardiothorac Vasc Anesth 2012; 16:59.</a></li><li><a class="nounderline abstract_t">Urmey WF, McDonald M. Hemidiaphragmatic paresis during interscalene brachial plexus block: effects on pulmonary function and chest wall mechanics. Anesth Analg 1992; 74:352.</a></li><li><a class="nounderline abstract_t">Gentili ME, Lefoulon-Gourves M, Mamelle JC, Bonnet F. Acute respiratory failure following interscalene block: complications of combined general and regional anesthesia. Reg Anesth 1994; 19:292.</a></li><li><a class="nounderline abstract_t">Kim ES, Bishop MJ. Endotracheal intubation, but not laryngeal mask airway insertion, produces reversible bronchoconstriction. Anesthesiology 1999; 90:391.</a></li><li><a class="nounderline abstract_t">Thwaites A, Edmends S, Smith I. Inhalation induction with sevoflurane: a double-blind comparison with propofol. Br J Anaesth 1997; 78:356.</a></li><li><a class="nounderline abstract_t">EGER EI 2nd, SEVERINGHAUS JW. EFFECT OF UNEVEN PULMONARY DISTRIBUTION OF BLOOD AND GAS ON INDUCTION WITH INHALATION ANESTHETICS. Anesthesiology 1964; 25:620.</a></li><li><a class="nounderline abstract_t">Eames WO, Rooke GA, Wu RS, Bishop MJ. Comparison of the effects of etomidate, propofol, and thiopental on respiratory resistance after tracheal intubation. Anesthesiology 1996; 84:1307.</a></li><li><a class="nounderline abstract_t">Bruder EA, Ball IM, Ridi S, et al. Single induction dose of etomidate versus other induction agents for endotracheal intubation in critically ill patients. Cochrane Database Syst Rev 2015; 1:CD010225.</a></li><li><a class="nounderline abstract_t">Rooke GA, Choi JH, Bishop MJ. The effect of isoflurane, halothane, sevoflurane, and thiopental/nitrous oxide on respiratory system resistance after tracheal intubation. Anesthesiology 1997; 86:1294.</a></li><li><a class="nounderline abstract_t">Goff MJ, Arain SR, Ficke DJ, et al. Absence of bronchodilation during desflurane anesthesia: a comparison to sevoflurane and thiopental. Anesthesiology 2000; 93:404.</a></li><li><a class="nounderline abstract_t">Dikmen Y, Eminoglu E, Salihoglu Z, Demiroluk S. Pulmonary mechanics during isoflurane, sevoflurane and desflurane anaesthesia. Anaesthesia 2003; 58:745.</a></li><li><a class="nounderline abstract_t">Conacher ID. Anaesthesia for the surgery of emphysema. Br J Anaesth 1997; 79:530.</a></li><li><a class="nounderline abstract_t">Bardoczky GI, d'Hollander AA, Cappello M, Yernault JC. Interrupted expiratory flow on automatically constructed flow-volume curves may determine the presence of intrinsic positive end-expiratory pressure during one-lung ventilation. Anesth Analg 1998; 86:880.</a></li><li><a class="nounderline abstract_t">Murphy GS, Brull SJ. Residual neuromuscular block: lessons unlearned. Part I: definitions, incidence, and adverse physiologic effects of residual neuromuscular block. Anesth Analg 2010; 111:120.</a></li><li><a class="nounderline abstract_t">Brull SJ, Murphy GS. Residual neuromuscular block: lessons unlearned. Part II: methods to reduce the risk of residual weakness. Anesth Analg 2010; 111:129.</a></li><li><a class="nounderline abstract_t">Grosse-Sundrup M, Henneman JP, Sandberg WS, et al. Intermediate acting non-depolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: prospective propensity score matched cohort study. BMJ 2012; 345:e6329.</a></li><li><a class="nounderline abstract_t">Liu SS, Wu CL. Effect of postoperative analgesia on major postoperative complications: a systematic update of the evidence. Anesth Analg 2007; 104:689.</a></li><li><a class="nounderline abstract_t">Lumb A, Biercamp C. Chronic obstructive pulmonary disease and anaesthesia. Contin Educ Anaesth Crit Care Pain 2014; 14:1.</a></li><li><a class="nounderline abstract_t">Glossop AJ, Shephard N, Bryden DC, Mills GH. Non-invasive ventilation for weaning, avoiding reintubation after extubation and in the postoperative period: a meta-analysis. Br J Anaesth 2012; 109:305.</a></li><li><a class="nounderline abstract_t">Chiumello D, Chevallard G, Gregoretti C. Non-invasive ventilation in postoperative patients: a systematic review. Intensive Care Med 2011; 37:918.</a></li><li><a class="nounderline abstract_t">Faria DA, da Silva EM, Atallah ÁN, Vital FM. Noninvasive positive pressure ventilation for acute respiratory failure following upper abdominal surgery. Cochrane Database Syst Rev 2015; :CD009134.</a></li><li><a class="nounderline abstract_t">Shah NM, D'Cruz RF, Murphy PB. Update: non-invasive ventilation in chronic obstructive pulmonary disease. J Thorac Dis 2018; 10:S71.</a></li><li><a class="nounderline abstract_t">Galizia G, Prizio G, Lieto E, et al. Hemodynamic and pulmonary changes during open, carbon dioxide pneumoperitoneum and abdominal wall-lifting cholecystectomy. A prospective, randomized study. Surg Endosc 2001; 15:477.</a></li><li><a class="nounderline abstract_t">Hsieh CH. Laparoscopic cholecystectomy for patients with chronic obstructive pulmonary disease. J Laparoendosc Adv Surg Tech A 2003; 13:5.</a></li><li><a class="nounderline abstract_t">Fahy BG, Barnas GM, Nagle SE, et al. Changes in lung and chest wall properties with abdominal insufflation of carbon dioxide are immediately reversible. Anesth Analg 1996; 82:501.</a></li></ol></div><div id="topicVersionRevision">Topic 94354 Version 33.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26704782" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Surgical outcomes in patients with chronic obstructive pulmonary disease undergoing abdominal operations: An analysis of 331,425 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27607099" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Predicting the Risk of Postoperative Respiratory Failure in Elective Abdominal and Vascular Operations Using the National Surgical Quality Improvement Program (NSQIP) Participant Use Data File.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21045639" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Prediction of postoperative pulmonary complications in a population-based surgical cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25210449" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Epidemiology and clinical impact of major comorbidities in patients with COPD.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16113462" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25085962" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25085962" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9389256" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Postoperative spirometry after laparoscopy for lower abdominal or upper abdominal surgical procedures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16618956" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Preoperative pulmonary risk stratification for noncardiothoracic surgery: systematic review for the American College of Physicians.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9932113" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Postural changes in respiratory function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9181161" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : The effect of patient positioning on dynamic lung compliance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7726438" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : The prone positioning during general anesthesia minimally affects respiratory mechanics while improving functional residual capacity and increasing oxygen tension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Prone position in artificially ventilated chronic obstructive pulmonary disease patients assessment of lung mechani</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10710406" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Regional ventilation-perfusion distribution is more uniform in the prone position.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1756845" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Chronic obstructive pulmonary disease and anaesthesia: formation of atelectasis and gas exchange impairment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29316890" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Risk factors of postoperative pulmonary complications in patients with asthma and COPD.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18268924" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Perioperative medical management of patients with COPD.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30998510" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Respiratory Physiology for the Anesthesiologist.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19011781" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Guideline-oriented perioperative management of patients with bronchial asthma and chronic obstructive pulmonary disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10434815" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Recovery after anaesthesia for pulmonary surgery: desflurane, sevoflurane and isoflurane.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/240480" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Criteria of fitness for anaesthesia in patients with chronic obstructive lung disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32040531" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Risk assessment for hospital admission in patients with COPD; a multi-centre UK prospective observational study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30604419" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Pre-operative respiratory optimisation: an expert review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32710678" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Pre-operative optimisation for chronic obstructive pulmonary disease: a narrative review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15114199" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Corticosteroids and inhaled salbutamol in patients with reversible airway obstruction markedly decrease the incidence of bronchospasm after tracheal intubation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25178099" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27101492" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Smoking Cessation: The Role of the Anesthesiologist.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15219010" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27554230" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Smoking Cessation Can Reduce the Incidence of Postoperative Hypoxemia After On-Pump Coronary Artery Bypass Grafting Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33186165" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Perioperative Lung Protection: General Mechanisms and Protective Approaches.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21059667" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : The effects of preoperative exercise therapy on postoperative outcome: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21059667" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : The effects of preoperative exercise therapy on postoperative outcome: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24182721" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Patients with chronic pulmonary disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22878278" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2919767" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Midazolam-morphine sedative interaction in patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23106947" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Oxygen-induced hypercapnia in COPD: myths and facts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25526396" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Regional versus general anesthesia in surgical patients with chronic obstructive pulmonary disease: does avoiding general anesthesia reduce the risk of postoperative complications?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21796055" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Epidural analgesia is associated with improved health outcomes of surgical patients with chronic obstructive pulmonary disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17072694" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Epidural anesthesia and pulmonary function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22018500" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Postoperative pulmonary function after open abdominal aortic aneurysm repair in patients with chronic obstructive pulmonary disease: epidural versus intravenous analgesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11873024" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Lung function under high thoracic segmental epidural anesthesia with ropivacaine or bupivacaine in patients with severe obstructive pulmonary disease undergoing breast surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24464831" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Neuraxial blockade for the prevention of postoperative mortality and major morbidity: an overview of Cochrane systematic reviews.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23897485" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Neuraxial anaesthesia for lower-limb revascularization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24096762" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Impact of epidural analgesia on mortality and morbidity after surgery: systematic review and meta-analysis of randomized controlled trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11118174" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22786494" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Epidural pain relief versus systemic opioid-based pain relief for abdominal aortic surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31708304" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Use of neuraxial anesthesia for hybrid lower extremity revascularization is associated with reduced perioperative morbidity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31617693" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Non-invasive ventilation during surgery under neuraxial anaesthesia: a pathophysiological perspective on application and benefits and a systematic literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31730291" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Comparison of preoperative versus postoperative transversus abdominis plane and rectus sheath block in patients undergoing minimally invasive colorectal surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22361819" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : End-stage pulmonary disease and brachial plexus regional anesthesia: their implications on perioperative pulmonary function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1539813" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Hemidiaphragmatic paresis during interscalene brachial plexus block: effects on pulmonary function and chest wall mechanics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7947432" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Acute respiratory failure following interscalene block: complications of combined general and regional anesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9952142" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Endotracheal intubation, but not laryngeal mask airway insertion, produces reversible bronchoconstriction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9135350" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Inhalation induction with sevoflurane: a double-blind comparison with propofol.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14211488" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : EFFECT OF UNEVEN PULMONARY DISTRIBUTION OF BLOOD AND GAS ON INDUCTION WITH INHALATION ANESTHETICS.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8669670" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Comparison of the effects of etomidate, propofol, and thiopental on respiratory resistance after tracheal intubation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25568981" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Single induction dose of etomidate versus other induction agents for endotracheal intubation in critically ill patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9197298" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : The effect of isoflurane, halothane, sevoflurane, and thiopental/nitrous oxide on respiratory system resistance after tracheal intubation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10910489" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Absence of bronchodilation during desflurane anesthesia: a comparison to sevoflurane and thiopental.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12859465" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Pulmonary mechanics during isoflurane, sevoflurane and desflurane anaesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9389276" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Anaesthesia for the surgery of emphysema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9539619" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Interrupted expiratory flow on automatically constructed flow-volume curves may determine the presence of intrinsic positive end-expiratory pressure during one-lung ventilation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20442260" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Residual neuromuscular block: lessons unlearned. Part I: definitions, incidence, and adverse physiologic effects of residual neuromuscular block.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20442261" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Residual neuromuscular block: lessons unlearned. Part II: methods to reduce the risk of residual weakness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23077290" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Intermediate acting non-depolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: prospective propensity score matched cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17312231" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Effect of postoperative analgesia on major postoperative complications: a systematic update of the evidence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Chronic obstructive pulmonary disease and anaesthesia</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22879654" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Non-invasive ventilation for weaning, avoiding reintubation after extubation and in the postoperative period: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21424246" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Non-invasive ventilation in postoperative patients: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26436599" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Noninvasive positive pressure ventilation for acute respiratory failure following upper abdominal surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29445530" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Update: non-invasive ventilation in chronic obstructive pulmonary disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11353965" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Hemodynamic and pulmonary changes during open, carbon dioxide pneumoperitoneum and abdominal wall-lifting cholecystectomy. A prospective, randomized study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12676014" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Laparoscopic cholecystectomy for patients with chronic obstructive pulmonary disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8623951" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Changes in lung and chest wall properties with abdominal insufflation of carbon dioxide are immediately reversible.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
